💥 Fed cuts sparks mid cap boom! ProPicks AI scores with 4 stocks +23% each. Get October’s update first.Pick Stocks with AI

WeightWatchers names new Chief Commercial and Impact Officers

Published 09/10/2024, 09:13 AM
WW
-

NEW YORK – WeightWatchers (NASDAQ: WW) has announced the appointment of Scott Honken as Chief Commercial Officer and Phillip Picardi as Chief Impact Officer. The new executives will join the leadership team in efforts to redefine community engagement and expand the company's business-to-business reach.


Scott Honken, coming from a background at Calibrate and other health-related organizations, is set to oversee B2B growth, operations, partnerships, and licensing. He aims to drive innovative growth opportunities and expand access to equitable care. Honken expressed enthusiasm about joining WeightWatchers, citing the brand's trusted reputation and science-backed programs.


Phillip Picardi, with his experience at the Los Angeles LGBT Center and a history in media, will lead efforts in building communities and scaling the company's impact work. He will focus on brand marketing, communications, social impact, and employee experience. Picardi highlighted the company's community-centric legacy as a key factor in his decision to join the team.


The CEO of WeightWatchers, Sima Sistani, expressed confidence that the expertise of the newly appointed officers would further the company's mission to empower people to live healthier lives. The appointments aim to propel WeightWatchers into a new chapter of growth, maintaining its position as a global leader in weight health.


WeightWatchers, known for its weight loss and management programs, combines technology and community to support members in reaching their health goals. The company offers services to both consumers and businesses, emphasizing a human-centric and clinically effective approach.


This announcement is based on a press release statement from WeightWatchers.


In other recent news, Weight Watchers International (WW) disclosed its second quarter 2024 financial results, indicating a blend of obstacles and strategic solutions. The company reported a 6% decline in subscribers year-over-year, totaling 3.8 million, and a decrease in revenue, which stood at $202 million for the quarter. However, Weight Watchers recorded a record high adjusted gross margin and provided a positive full-year guidance. The company has embarked on a restructuring plan aimed at cost reduction and operational efficiency enhancement, while also focusing on expanding its clinical business and optimizing product offerings.


The restructuring plan includes a 40% reduction in VP and above positions, projected to save $60 million annually. Despite a decline in subscription revenues, the company saw a nearly 120% increase in clinical subscribers, contributing to a $20 million clinical revenue. For the full year 2024, Weight Watchers expects at least 3.1 million subscribers, $770 million in revenue, $100 million in adjusted operating income, and $150 million in adjusted EBITDA.


These recent developments indicate the company's proactive approach to navigating a complex market environment and its commitment to delivering on profitability targets. Weight Watchers is also exploring alternative paths to improve access and health equity, emphasizing long-term commitment plans for digital services to optimize revenue.


InvestingPro Insights


As WeightWatchers (NASDAQ: WW) gears up for a new chapter with the recent executive appointments, the company's financial health and market performance offer insights into the challenges and opportunities ahead. According to InvestingPro data, WeightWatchers has a market capitalization of approximately $57.41 million, reflecting the current valuation of the company in the market. Despite an impressive gross profit margin of 65.82% over the last twelve months as of Q2 2024, the company has experienced a revenue decline of 11.89% during the same period, indicating potential headwinds in sales growth.


The company's stock price volatility is also noteworthy, with a one-month price total return showing a significant decrease of 28.7%. This high price volatility, an InvestingPro Tip, suggests that investors may face a bumpy road in the short term. Moreover, the stock is trading near its 52-week low, at only 5.41% of its highest value in the past year, which could signal a potential buying opportunity for investors who believe in the company's long-term strategy and the value that the new executives could bring to the table.


For those considering an investment in WeightWatchers, it's important to note that analysts have revised their earnings expectations downwards for the upcoming period, another InvestingPro Tip that could impact investor sentiment. For individuals seeking more comprehensive analysis, InvestingPro offers additional tips on the company's financial health and market performance. To explore further, visit https://www.investing.com/pro/WW, where more than 15 InvestingPro Tips are available to help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.